BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17322299)

  • 21. Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1.
    Takahra T; Smart DE; Oakley F; Mann DA
    Int J Biochem Cell Biol; 2004 Feb; 36(2):353-63. PubMed ID: 14643899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases, the pros and cons, in liver fibrosis.
    Han YP
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3(Suppl 3):S88-91. PubMed ID: 16958682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of pro-(matrix metalloproteinase-2) (pro-MMP-2) by thrombin is membrane-type-MMP-dependent in human umbilical vein endothelial cells and generates a distinct 63 kDa active species.
    Lafleur MA; Hollenberg MD; Atkinson SJ; Knäuper V; Murphy G; Edwards DR
    Biochem J; 2001 Jul; 357(Pt 1):107-15. PubMed ID: 11415441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase-2 and -9 are activated in joint diseases.
    Clegg PD; Carter SD
    Equine Vet J; 1999 Jul; 31(4):324-30. PubMed ID: 10454092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
    Cheng Y; Ping J; Xu LM
    Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB; Li DG; Lu HM
    J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation.
    Cortez DM; Feldman MD; Mummidi S; Valente AJ; Steffensen B; Vincenti M; Barnes JL; Chandrasekar B
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3356-65. PubMed ID: 17921324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2.
    Toth M; Bernardo MM; Gervasi DC; Soloway PD; Wang Z; Bigg HF; Overall CM; DeClerck YA; Tschesche H; Cher ML; Brown S; Mobashery S; Fridman R
    J Biol Chem; 2000 Dec; 275(52):41415-23. PubMed ID: 10998420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation.
    Zhao H; Bernardo MM; Osenkowski P; Sohail A; Pei D; Nagase H; Kashiwagi M; Soloway PD; DeClerck YA; Fridman R
    J Biol Chem; 2004 Mar; 279(10):8592-601. PubMed ID: 14681236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase.
    Schwartz JD; Shamamian P; Monea S; Whiting D; Marcus SG; Galloway AC; Mignatti P
    Surgery; 1998 Aug; 124(2):232-8. PubMed ID: 9706143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of matrix metallo-proteinase expression by extracellular matrix components in cultured hepatic stellate cells.
    Wang DR; Sato M; Sato T; Kojima N; Higashi N; Senoo H
    Comp Hepatol; 2004 Jan; 3 Suppl 1(Suppl 1):S20. PubMed ID: 14960172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.
    Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P
    J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow mononuclear cell transplantation increases metalloproteinase-9 and 13 and decreases tissue inhibitors of metalloproteinase-1 and 2 expression in the liver of cholestatic rats.
    Nunes de Carvalho S; Helal-Neto E; de Andrade DC; Costa Cortez EA; Thole AA; Barja-Fidalgo C; de Carvalho L
    Cells Tissues Organs; 2013; 198(2):139-48. PubMed ID: 23886643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a highly selective chemical inhibitor of matrix metalloproteinase-9 (MMP-9) that allosterically inhibits zymogen activation.
    Scannevin RH; Alexander R; Haarlander TM; Burke SL; Singer M; Huo C; Zhang YM; Maguire D; Spurlino J; Deckman I; Carroll KI; Lewandowski F; Devine E; Dzordzorme K; Tounge B; Milligan C; Bayoumy S; Williams R; Schalk-Hihi C; Leonard K; Jackson P; Todd M; Kuo LC; Rhodes KJ
    J Biol Chem; 2017 Oct; 292(43):17963-17974. PubMed ID: 28860188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential role of p38 in IL-1alpha induction of MMP-9 and MMP-13 in an established liver myofibroblast cell line.
    Lee HS; Miau LH; Chen CH; Chiou LL; Huang GT; Yang PM; Sheu JC
    J Biomed Sci; 2003; 10(6 Pt 2):757-65. PubMed ID: 14631115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase.
    Shimada T; Nakamura H; Ohuchi E; Fujii Y; Murakami Y; Sato H; Seiki M; Okada Y
    Eur J Biochem; 1999 Jun; 262(3):907-14. PubMed ID: 10411655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
    Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G
    Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of treatment with Maraviroc a CCR5 inhibitor on a human hepatic stellate cell line.
    Coppola N; Perna A; Lucariello A; Martini S; Macera M; Carleo MA; Guerra G; Esposito V; De Luca A
    J Cell Physiol; 2018 Aug; 233(8):6224-6231. PubMed ID: 29336497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats.
    Abramovitch S; Dahan-Bachar L; Sharvit E; Weisman Y; Ben Tov A; Brazowski E; Reif S
    Gut; 2011 Dec; 60(12):1728-37. PubMed ID: 21816960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.